• Pain
• Immuno-Inflammatory

 

Zalicus Pipeline: Focused on Pain and Inflammation

Zalicus focuses its internal drug development efforts on pain and immuno-inflammatory programs.  Our pipeline includes Synavive^®, which is in Phase 2 development for arthritis, and our Ion channel program, which is advancing a lead candidate into clinical development for pain.